Best Laser for Scar Reduction
For hypertrophic and atrophic scars, fractional CO2 laser provides the most consistent and significant improvements in scar height, texture, and pigmentation, with the strongest evidence supporting its use either alone or in combination with pulsed dye laser (PDL).
Primary Recommendation: Fractional CO2 Laser
The fractional CO2 laser demonstrates stable and significant improvements in pliability and texture across multiple scar types 1. Recent evidence from 2026 shows that fractional CO2 laser therapy achieves a 100% overall effective rate for facial pigmented scars, with total POSAS scores decreasing from 83.97 to 33.56 points after an average of 5.44 treatment sessions 2. This represents the most robust quantitative outcome data available.
Key Performance Metrics:
- VSS scoring efficacy: 57.5% for ablative fractional laser 3
- POSAS scoring efficacy: 40.4% for ablative fractional laser 3
- Average treatment sessions required: 3.43 3
Secondary Option: Pulsed Dye Laser (PDL)
PDL is particularly effective for reducing scar height and vascularity 1. The 585-nm PDL shows low-certainty evidence of improvement compared to no treatment (RR 1.96; 95% CI: 1.11 to 3.45) 4. However, PDL demonstrates slightly lower efficacy metrics:
Optimal Strategy: Combination Therapy
The combination of fractional CO2 laser plus PDL achieves superior results with fewer treatment sessions 3. When combined:
- Average sessions reduced to 1.5 (versus 3.43-3.68 for monotherapy)
- Greater effectiveness than either method alone
- No severe adverse reactions reported 3
The synergistic mechanism involves fractional CO2 creating microthermal injury for collagen remodeling while PDL targets vascularity and erythema 5.
Treatment Algorithm by Scar Type
For Hypertrophic Scars:
- First-line: Fractional CO2 laser (3-5 sessions, 4-6 week intervals)
- Add PDL if significant vascularity or erythema persists
- Consider combination therapy upfront for faster results
For Atrophic Scars:
- First-line: Fractional CO2 laser for texture and depth improvement
- Combine with PRP application post-laser for enhanced healing 5
For Pigmented Scars:
- First-line: Fractional CO2 laser with moist wound healing protocol 2
- Monitor melanin index quantitatively—65% of patients show decreased hyperpigmentation 6
- Use erythromycin ophthalmic ointment post-procedure to prevent PIH 2
Critical Timing Considerations
Early intervention is crucial. Red LED photobiomodulation shows greater benefits in scars less than 12 months old 7. Apply this principle to laser therapy—treat scars as early as safely possible after wound maturation.
Adjunctive Therapy to Enhance Outcomes
When combining laser with autologous platelet concentrates (PRP):
- Apply PRP immediately after laser treatment, not before 5
- PRP reduces downtime by 50% and decreases erythema/edema duration (p=0.02) 5
- Topical PRP application is as effective as intradermal injection with less pain 5
Safety Profile and Adverse Events
Fractional CO2 laser adverse events are predominantly mild and transient 2:
- Erythema and edema (self-limited)
- Transient PIH in 8.8% of patients (resolves within 3 months)
- No permanent depigmentation or scar aggravation reported
Critical caveat: Avoid fully ablative laser treatments and mechanical dermabrasion in the early post-operative period 8. Wait for adequate wound maturation.
What Doesn't Work
The evidence does not support pneumatic broadband light added to topical therapies—it fails to reduce lesion counts and carries risks of hyperpigmentation and purpura 9. The 1726 nm laser lacks RCT evidence and cannot be recommended 9.
Practical Treatment Parameters
For fractional CO2 laser 2:
- Multiple sessions (average 5-6 treatments)
- 4-6 week intervals between sessions
- Post-treatment moist healing with topical antibiotic ointment
- Quantitative assessment using POSAS scores and melanin index
The evidence strongly favors fractional CO2 laser as the gold standard, with combination therapy offering the most efficient path to optimal outcomes across multiple scar dimensions.